雅虎香港 搜尋

搜尋結果

  1. 2022年8月19日 · HANGZHOU, Aug 19, 2022 - (ACN Newswire) - New Horizon Health (6606.HK), China's leading biotechnology company for early cancer screening, announced its half-year results for the year ended June 30, 2022 today. Based on the financial information before the audit as of June 30, 2022, New Horizon Health achieved total revenue of RMB226 million in ...